Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression

Bromodomain 4 (BRD4) is an epigenetic regulator that, when inhibited, has anti-cancer effects. In this study, we investigated whether BRD4 could be a target for treatment of human hepatocellular carcinoma (HCC). We show that BRD4 is over-expressed in HCC tissues. Suppression of BRD4, either by siRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Gong-Quan, Guo, Wen-Zhi, Zhang, Yi, Seng, Jing-Jing, Zhang, Hua-Peng, Ma, Xiu-Xian, Zhang, Gong, Li, Jie, Yan, Bing, Tang, Hong-Wei, Li, Shan-Shan, Wang, Li-Dong, Zhang, Shui-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823048/
https://www.ncbi.nlm.nih.gov/pubmed/26575167
http://dx.doi.org/10.18632/oncotarget.6275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823048/
https://www.ncbi.nlm.nih.gov/pubmed/26575167
http://dx.doi.org/10.18632/oncotarget.6275

Ejemplares similares